Powder: -20°C for 3 years | In solvent: -80°C for 1 year
HIF-1α-IN-5 is an inhibitor of HIF-1α with an IC 50 value of 24 nM in HEK293T cells that also inhibits the activity of MAO-A. HIF-1α-IN-5 downregulates the mRNA expressions of VEGF and PDK1 under hypoxia. HIF-1α-IN-5 has the potential to be used in the cancer research[1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 1,520.00 | |
50 mg | 10-14 weeks | $ 1,980.00 | |
100 mg | 10-14 weeks | $ 2,500.00 |
Description | HIF-1α-IN-5 is an inhibitor of HIF-1α with an IC 50 value of 24 nM in HEK293T cells that also inhibits the activity of MAO-A. HIF-1α-IN-5 downregulates the mRNA expressions of VEGF and PDK1 under hypoxia. HIF-1α-IN-5 has the potential to be used in the cancer research[1]. |
In vitro | HIF-1α-IN-5 (compound 15, 24 h) demonstrates inhibitory effects on HIF-1α transcription within HEK293T cells, exhibiting an IC50 value of 24 nM. In the same cell line and time frame, it dose-dependently decreases VEGF and PDK1 mRNA levels under hypoxic conditions, as verified by RT-PCR. Additionally, at a concentration of 10 μM, HIF-1α-IN-5 significantly reduces MAO-A and ADORA2A activities by 80.64% and 43.95%, respectively. |
Molecular Weight | 281.31 |
Formula | C16H15N3O2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.